HEMOSTEMIX INC (HMTXF:OTCMKTS)
$0.0548 0.0052 (10.4839%)
Analysed HEMOSTEMIX INC (HMTXF:OTCMKTS) News Sources
Hemostemix Closes $480,000 Private Placement at $0.12 per Share
31-12-2025
yahoo.com
Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships
03-02-2026
yahoo.com
Hemostemix' $1,000,000 Private Placement and Update
17-06-2026
yahoo.com
Hemostemix Closes $360,000 First Tranche of Private Placement
26-06-2026
yahoo.com
Commercialization Application Filed by Hemostemix for the Treatment of Vascular Dementia, Angina and Pain
08-07-2026
yahoo.com
Hemostemix Grants Stock Options
22-07-2026
yahoo.com
Hemostemix' Longevity Phase I Clinical Trial Leveraging VesCell(TM)'s Excellent Results
28-07-2026
yahoo.com
Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026
30-07-2026
yahoo.com
Dr. Ernst von Schwarz, Principal Investigator of Hemostemix VesCell(TM) Longevity Clinical Trial
12-08-2026
yahoo.com
Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTA
20-08-2026
yahoo.com
What is the current price of HEMOSTEMIX INC (HMTXF:OTCMKTS)?
The current price of HEMOSTEMIX INC (HMTXF:OTCMKTS) is $0.0548.
HEMOSTEMIX INC (HMTXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of HEMOSTEMIX INC (HMTXF:OTCMKTS) since the previous trading day is $0.0052.
HEMOSTEMIX INC (HMTXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of HEMOSTEMIX INC (HMTXF:OTCMKTS) since the previous trading day is 10.4839%.
What is the most recent average sentiment score for HEMOSTEMIX INC (HMTXF:OTCMKTS)?
The most recent average sentiment score for HEMOSTEMIX INC (HMTXF:OTCMKTS) is 65 out of 100.
What is the most recent average sentiment for HEMOSTEMIX INC (HMTXF:OTCMKTS)?
The most recent sentiment for HEMOSTEMIX INC (HMTXF:OTCMKTS) is .
SEC-8K** Filing Available For HEMOSTEMIX INC (HMTXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.